Suppr超能文献

纳米纤维素在药物结合和控制释放中的应用。

The use of nanocrystalline cellulose for the binding and controlled release of drugs.

机构信息

Faculty of Pharmaceutical Sciences, University of British Columbia, 2146 East Mall, Vancouver, BC, Canada.

出版信息

Int J Nanomedicine. 2011;6:321-30. doi: 10.2147/IJN.S16749. Epub 2011 Feb 10.

Abstract

The objective of this work was to investigate the use of nanocrystalline cellulose (NCC) as a drug delivery excipient. NCC crystallites, prepared by an acid hydrolysis method, were shown to have nanoscopic dimensions and exhibit a high degree of crystallinity. These crystallites bound significant quantities of the water soluble, ionizable drugs tetratcycline and doxorubicin, which were released rapidly over a 1-day period. Cetyl trimethylammonium bromide (CTAB) was bound to the surface of NCC and increased the zeta potential in a concentration-dependent manner from -55 to 0 mV. NCC crystallites with CTAB-modified surfaces bound significant quantities of the hydrophobic anticancer drugs docetaxel, paclitaxel, and etoposide. These drugs were released in a controlled manner over a 2-day period. The NCC-CTAB complexes were found to bind to KU-7 cells, and evidence of cellular uptake was observed.

摘要

本工作旨在研究纳米晶纤维素 (NCC) 作为药物传递赋形剂的用途。通过酸水解法制备的 NCC 晶须具有纳米级尺寸,表现出高度的结晶度。这些晶须结合了大量的水溶性、可离子化药物四环素和阿霉素,在 1 天内迅速释放。十六烷基三甲基溴化铵 (CTAB) 结合到 NCC 的表面,并以浓度依赖的方式使 Zeta 电位从 -55mV 增加至 0mV。具有 CTAB 修饰表面的 NCC 晶须结合了大量疏水性抗癌药物多西紫杉醇、紫杉醇和依托泊苷。这些药物在 2 天内以受控方式释放。发现 NCC-CTAB 复合物能够结合 KU-7 细胞,并观察到细胞摄取的证据。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9251/3044185/741b3e9d21ad/ijn-6-321f4.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验